Inj, aflibercept-boav, 1 mg
Full descriptor
Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg
Details
- Code
- Q5170
- Short descriptor
- Inj, aflibercept-boav, 1 mg
- Code set
- HCPCS Level II
- Release
- July 2026
- Status
- Active
- Added
- Jul 1 2026
Nearby codes
Code sets are published in blocks, so neighbours are usually related.
Inj, armlupeg, 0.5 mg
Inj, den (boncres), bio, 1mg
Inj. nufymco, 0.1 mg
Inj, denosumab-qbde, 1 mg
Inj, denosumab-desu, 1 mg
Inj, denosumab-mobz, 1 mg
Ustekinumab-hmny, 1 mg
Inj, denosumab-nxxp, 1 mg
Sources
- CMS HCPCS Level II — July 2026, public domain
Reference information only. Not billing advice. Verify against the payer before you file.